Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $225.28 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $38.48 | 2 | $0 (2021) |
| GlaxoSmithKline, LLC. | $34.82 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $31.13 | 2 | $0 (2021) |
| Lilly USA, LLC | $28.77 | 2 | $0 (2021) |
| Amarin Pharma Inc. | $22.59 | 1 | $0 (2021) |
| Organogenesis Inc. | $18.72 | 1 | $0 (2023) |
| Currax Pharmaceuticals LLC | $14.31 | 1 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $12.70 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $11.99 | 1 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $11.77 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $31.42 | 2 | Organogenesis Inc. ($18.72) |
| 2022 | $14.31 | 1 | Currax Pharmaceuticals LLC ($14.31) |
| 2021 | $179.55 | 11 | Astellas Pharma US Inc ($38.48) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/13/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $18.72 | General |
| Category: Wound Care | ||||||
| 03/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Cardio-renal | ||||||
| 02/09/2022 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Obesity | ||||||
| 03/15/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Diabetes | ||||||
| 03/12/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: RESPIRATORY | ||||||
| 03/08/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Cardiovascular | ||||||
| 02/26/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Respiratory | ||||||
| 02/19/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: UROLOGY | ||||||
| 02/17/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: RESPIRATORY | ||||||
| 01/23/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/20/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Respiratory | ||||||
| 01/18/2021 | Lilly USA, LLC | GLYXAMBI (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Diabetes | ||||||
| 01/13/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: UROLOGY | ||||||
| 01/12/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 474 | 495 | $82,229 | $21,883 |
| 2022 | 6 | 345 | 349 | $47,149 | $15,776 |
| 2021 | 6 | 547 | 603 | $81,444 | $27,389 |
| 2020 | 6 | 657 | 886 | $141,825 | $36,920 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 251 | 260 | $50,170 | $13,325 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 47 | $10,571 | $3,453 | 32.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $6,289 | $1,594 | 25.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 25 | 25 | $3,410 | $1,257 | 36.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 28 | 28 | $2,204 | $969.36 | 44.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 35 | 35 | $6,943 | $504.93 | 7.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 15 | 26 | $676.52 | $421.72 | 62.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 18 | 18 | $1,548 | $291.60 | 18.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 29 | 30 | $418.40 | $66.00 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 181 | 185 | $27,555 | $8,409 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 42 | $8,098 | $3,396 | 41.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 64 | 64 | $8,862 | $3,203 | 36.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 15 | $1,227 | $419.36 | 34.2% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 17 | 17 | $1,181 | $290.15 | 24.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 26 | 26 | $226.04 | $57.84 | 25.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 205 | 223 | $34,251 | $10,905 | 31.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 107 | 129 | $28,776 | $7,950 | 27.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 70 | 80 | $5,744 | $3,218 | 56.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 57 | 58 | $6,257 | $3,216 | 51.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 30 | 30 | $4,584 | $1,539 | 33.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 12 | $1,140 | $372.80 | 32.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 35 | 38 | $266.00 | $114.00 | 42.9% |
| 81003 | Automated urinalysis test | Office | 2021 | 31 | 33 | $426.36 | $74.25 | 17.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 267 | 415 | $90,501 | $23,801 | 26.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 181 | 236 | $34,773 | $9,466 | 27.2% |
About Rachel Hamilton, CNP
Rachel Hamilton, CNP is a Family healthcare provider based in Ontario, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1417344755.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rachel Hamilton, CNP has received a total of $225.28 in payments from pharmaceutical and medical device companies, with $31.42 received in 2023. These payments were reported across 14 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($225.28).
As a Medicare-enrolled provider, Hamilton has provided services to 2,023 Medicare beneficiaries, totaling 2,333 services with total Medicare billing of $101,967. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Ontario, OH
- Active Since 04/24/2015
- Last Updated 04/04/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1417344755
Products in Payments
- MYRBETRIQ (Drug) $38.48
- BREZTRI (Drug) $31.13
- Vascepa (Drug) $22.59
- Puraply (Medical Supply) $18.72
- ANORO ELLIPTA (Drug) $18.51
- TRELEGY ELLIPTA (Drug) $16.31
- GLYXAMBI (Drug) $15.57
- CONTRAVE (Drug) $14.31
- TRULICITY (Drug) $13.20
- Kerendia (Drug) $12.70
- XARELTO (Drug) $11.99
- NURTEC ODT (Drug) $11.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Ontario
Amber Campbell, Cnp, CNP
Family — Payments: $8,036
Natalie Roby, N.p, N.P
Family — Payments: $5,161
Patty Fleming, Cnp, CNP
Family — Payments: $4,259
Mrs. Julie Burkhart, Aprn, Np-C, APRN, NP-C
Family — Payments: $3,466
Kiersten Hogg, Dnp, Fnp, DNP, FNP
Family — Payments: $2,728
Mr. Michael Conley, Np, NP
Family — Payments: $2,477